Proof of concept for a rapidly switchable universal CAR-T platform with UniCAR-T-CD123 in relapsed/refractory AML

Martin Wermke1,2, Sabrina Kraus3, Armin Ehninger4

  • 1Division of Hematology, Oncology and Stem Cell Transplantation, Medical Clinic I, Department of Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.

Blood
|February 24, 2021
PubMed
Abstract

No abstract available in PubMed .